Teehan Brendan 4
4 · Pacira BioSciences, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Teehan Brendan
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-12-31$10.76/sh+402.268$4,330→ 54,402.268 total
Footnotes (1)
- [F1]Represents shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.